A Multicenter, Prospective Study of Perioperative Finotonlimab Combined With Bevacizumab in Resectable Hepatocellular Carcinoma Patients With High-Risk Factors for Recurrence
Clinical trial NCT07009470 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07009470
- Sponsor
- Tongji Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-10
- Primary completion
- 2028-04-28
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.